Phase Forward

Robert Weiler is the CEO of Phase Forward. To contact Robert Weiler email at [email protected].

The decision makers in Phase Forward are Carolyn Williams, Dana Crawford, Gary Parrott, etc. Click to Find Phase Forward decision makers emails.

Phase Forward provides a comprehensive suite of clinical data management solutions that include electronic data capture (EDC), clinical trial management systems (CTMS), and data analytics tools. These solutions are designed to streamline the data collection process, enhance data quality, and ensure regulatory compliance throughout the clinical trial lifecycle.

Phase Forward employs a multi-layered approach to data security, including encryption, access controls, and regular security audits. Our solutions are designed to comply with global regulatory standards such as FDA 21 CFR Part 11 and GDPR, ensuring that sensitive patient data is protected and that our clients meet all necessary compliance requirements.

Yes, Phase Forward has extensive experience supporting clinical trials across a wide range of therapeutic areas, including oncology, cardiology, neurology, and rare diseases. Our flexible solutions can be tailored to meet the specific needs of various studies, ensuring that we can effectively support diverse research initiatives.

Phase Forward offers a range of global services, including project management, data management, biostatistics, and regulatory consulting. Our team of experts works closely with clients to provide end-to-end support, from study design to data analysis, ensuring that trials are conducted efficiently and effectively across different regions.

Phase Forward's award-winning technology enhances the efficiency of clinical trials by automating data collection processes, reducing manual data entry errors, and providing real-time access to data analytics. This allows clinical teams to make informed decisions quickly, monitor trial progress, and address issues proactively, ultimately accelerating the time to market for new therapies.

In addition to serving the pharmaceutical industry, Phase Forward also supports biotechnology companies, medical device manufacturers, and academic research organizations. Our integrated data management solutions are adaptable to various research environments, making them suitable for a wide range of clinical and safety studies across different sectors.